The association of FOXP3-positive CD4+ Treg cells with prognosis and progression of cancer is well established1, 2, but the role of CD8+ Tregs in cancer is not clearly deciphered yet, due to lack of universal phenotypic signature which could distinguish CD8+ Tregs from conventional CD8+ T cells. This evidence concerns the gene FOXP3 and cancer.